FDA Label for Rotosxika Prostate Patch
View Indications, Usage & Precautions
Rotosxika Prostate Patch Product Label
The following document was submitted to the FDA by the labeler of this product Puning Xinhua Trade Co., Ltd.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Active Ingredient: Adrenal gland 1g/100g, Chelidonium majus 1g/100g, Menthol 5g/100g
Otc - Purpose
Purpose: Prostate pain
Indications & Usage
Use to:
Temporarily alleviate the following symptoms: pain in the spermatic cord, testicles, liver, and prostate.
Dosage & Administration
Directions
Usage and dosage:External use. Open the packaging, remove the backing paper, and apply it to the Shenque acupoint (navel) and Shenshu acupoints every 6-8 hours per day.
Warnings
Precautions
1.This product is an external product, do not take it internally;
2.This product is a health care product and does not replace drugs and medical devices fortreatment;
3.Pregnant women, infants, breastfeeding, and those allergic to this product are prohibited;
4.Do not use skin allergies, skin damage, skin diseases and other symptoms;
5.If the skin appears red, itchy and other abnormal conditions during use, please suspend use.
Otc - Questions
Questions or comments?
+8617846992567
Inactive Ingredient
Inactive ingredients: 25% Ethanol
Statement Of Identity
Other information:
Sealed packaging,please keep in a cool and dark place.
Produced by:
Nanyang Jingzhilan Biotechnology Co., Ltd
No.6,Road2,Longsheng Industrial Park,Wangcun Township, Wolong District, Nanyang City
OEM Company: Puning Xinhua Trade Co., Ltd
Made in China
Otc - Keep Out Of Reach Of Children
Same as WARNINGS SECTION
Package Label.Principal Display Panel
Label
* Please review the disclaimer below.
